Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult Participants
Phase 1
Completed
- Conditions
- Food Effect in Healthy Participants
- Interventions
- Drug: CRS3123 200 mg capsule
- First Posted Date
- 2025-05-23
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Crestone, Inc
- Target Recruit Count
- 17
- Registration Number
- NCT06988423
- Locations
- 🇺🇸
Syneos Health Miami, Miami, Florida, United States
Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection
Phase 2
Completed
- Conditions
- Clostridioides Difficile Infection
- Interventions
- Drug: Active Comparator
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Crestone, Inc
- Target Recruit Count
- 43
- Registration Number
- NCT04781387
- Locations
- 🇺🇸
131, Fullerton, California, United States
🇺🇸117, Lancaster, California, United States
🇺🇸143, Mission Hills, California, United States
News
No news found